Robert J. Parmer - Publications

Affiliations: 
University of California, San Diego and San Diego State University 
Area:
Public Health, Biochemistry

106 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Miles LA, Parmer RJ. Angry macrophages patrol for fibrin. Blood. 127: 1079-80. PMID 26941388 DOI: 10.1182/blood-2016-01-687673  0.48
2014 Miles LA, Parmer RJ. Setting the table for macrophages. Blood. 124: 665-6. PMID 25082858 DOI: 10.1182/blood-2014-06-579631  0.48
2014 Miles LA, Lighvani S, Baik N, Parmer CM, Khaldoyanidi S, Mueller BM, Parmer RJ. New insights into the role of Plg-RKT in macrophage recruitment. International Review of Cell and Molecular Biology. 309: 259-302. PMID 24529725 DOI: 10.1016/B978-0-12-800255-1.00005-3  0.48
2013 Gingles NA, Bai H, Miles LA, Parmer RJ. Peptidergic regulation of plasminogen activator inhibitor-1 gene expression in vivo. Journal of Thrombosis and Haemostasis : Jth. 11: 1707-15. PMID 23800036 DOI: 10.1111/jth.12333  0.48
2013 Miles LA, Parmer RJ. Plasminogen receptors: the first quarter century. Seminars in Thrombosis and Hemostasis. 39: 329-37. PMID 23532575 DOI: 10.1055/s-0033-1334483  0.48
2012 Miles LA, Plow EF, Waisman DM, Parmer RJ. Plasminogen receptors. Journal of Biomedicine & Biotechnology. 2012: 130735. PMID 23226936 DOI: 10.1155/2012/130735  0.48
2012 Miles LA, Lighvani S, Baik N, Andronicos NM, Chen EI, Parmer CM, Khaldoyanidi S, Diggs JE, Kiosses WB, Kamps MP, Yates JR, Parmer RJ. The plasminogen receptor, Plg-R(KT), and macrophage function. Journal of Biomedicine & Biotechnology. 2012: 250464. PMID 23125524 DOI: 10.1155/2012/250464  0.48
2012 Bai H, Nangia S, Parmer RJ. The plasminogen activation system and the regulation of catecholaminergic function. Journal of Biomedicine & Biotechnology. 2012: 721657. PMID 23097598 DOI: 10.1155/2012/721657  0.48
2012 Félez J, Jardí M, Fàbregas P, Parmer RJ, Miles LA. Monoclonal antibodies against receptor-induced binding sites detect cell-bound plasminogen in blood. Blood. 120: 678-81. PMID 22649107 DOI: 10.1182/blood-2012-02-410480  0.48
2011 Lighvani S, Baik N, Diggs JE, Khaldoyanidi S, Parmer RJ, Miles LA. Regulation of macrophage migration by a novel plasminogen receptor Plg-R KT. Blood. 118: 5622-30. PMID 21940822 DOI: 10.1182/blood-2011-03-344242  0.48
2011 Bai H, Baik N, Kiosses WB, Krajewski S, Miles LA, Parmer RJ. The novel plasminogen receptor, plasminogen receptor(KT) (Plg-R(KT)), regulates catecholamine release. The Journal of Biological Chemistry. 286: 33125-33. PMID 21795689 DOI: 10.1074/jbc.M111.218693  0.48
2011 Han J, Baik N, Kim KH, Yang JM, Han GW, Gong Y, Jardí M, Castellino FJ, Felez J, Parmer RJ, Miles LA. Monoclonal antibodies detect receptor-induced binding sites in Glu-plasminogen. Blood. 118: 1653-62. PMID 21680799 DOI: 10.1182/blood-2010-11-316943  0.48
2011 Jiang Q, Gingles NA, Olivier MA, Miles LA, Parmer RJ. The anti-fibrinolytic SERPIN, plasminogen activator inhibitor 1 (PAI-1), is targeted to and released from catecholamine storage vesicles. Blood. 117: 7155-63. PMID 21596853 DOI: 10.1182/blood-2010-05-287672  0.48
2010 Miles LA, Parmer RJ. S100A10: a complex inflammatory role. Blood. 116: 1022-4. PMID 20724548 DOI: 10.1182/blood-2010-05-284083  0.48
2010 Miles LA, Parmer RJ. PAI-1: cardiac friend or foe? Blood. 115: 1862-3. PMID 20223930 DOI: 10.1182/blood-2010-01-261420  0.48
2010 Andronicos NM, Chen EI, Baik N, Bai H, Parmer CM, Kiosses WB, Kamps MP, Yates JR, Parmer RJ, Miles LA. Proteomics-based discovery of a novel, structurally unique, and developmentally regulated plasminogen receptor, Plg-RKT, a major regulator of cell surface plasminogen activation. Blood. 115: 1319-30. PMID 19897580 DOI: 10.1182/blood-2008-11-188938  0.48
2009 Gutiérrez-Fernández A, Gingles NA, Bai H, Castellino FJ, Parmer RJ, Miles LA. Plasminogen enhances neuritogenesis on laminin-1. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 12393-400. PMID 19812315 DOI: 10.1523/JNEUROSCI.3553-09.2009  0.48
2007 Gutiérrez-Fernández A, Parmer RJ, Miles LA. Plasminogen gene expression is regulated by nerve growth factor. Journal of Thrombosis and Haemostasis : Jth. 5: 1715-25. PMID 17663741 DOI: 10.1111/j.1538-7836.2007.02636.x  0.48
2006 Miles LA, Andronicos NM, Baik N, Parmer RJ. Cell-surface actin binds plasminogen and modulates neurotransmitter release from catecholaminergic cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 13017-24. PMID 17167091 DOI: 10.1523/JNEUROSCI.2070-06.2006  0.48
2005 Miles LA, Hawley SB, Baik N, Andronicos NM, Castellino FJ, Parmer RJ. Plasminogen receptors: the sine qua non of cell surface plasminogen activation. Frontiers in Bioscience : a Journal and Virtual Library. 10: 1754-62. PMID 15769664  0.48
2004 Bannach FG, Gutierrez-Fernandez A, Parmer RJ, Miles LA. Interleukin-6-induced plasminogen gene expression in murine hepatocytes is mediated by transcription factor CCAAT/enhancer binding protein beta (C/EBPbeta). Journal of Thrombosis and Haemostasis : Jth. 2: 2205-12. PMID 15613028 DOI: 10.1111/j.1538-7836.2004.01022.x  0.48
2004 Le Corre P, Parmer RJ, Kailasam MT, Kennedy BP, Skaar TP, Ho H, Leverge R, Smith DW, Ziegler MG, Insel PA, Schork NJ, Flockhart DA, O'connor DT. Human sympathetic activation by alpha2-adrenergic blockade with yohimbine: Bimodal, epistatic influence of cytochrome P450-mediated drug metabolism. Clinical Pharmacology and Therapeutics. 76: 139-53. PMID 15289791 DOI: 10.1016/j.clpt.2004.04.010  0.48
2003 Lee JC, Taylor CV, Gaucher SP, Toneff T, Taupenot L, Yasothornsrikul S, Mahata SK, Sei C, Parmer RJ, Neveu JM, Lane WS, Gibson BW, O'Connor DT, Hook VY. Primary sequence characterization of catestatin intermediates and peptides defines proteolytic cleavage sites utilized for converting chromogranin a into active catestatin secreted from neuroendocrine chromaffin cells. Biochemistry. 42: 6938-46. PMID 12795588 DOI: 10.1021/bi0300433  0.48
2003 Chitbangonsyn SW, Mahboubi P, Walker D, Rana BK, Diggle KL, Timberlake DS, Parmer RJ, O'Connor DT. Physical mapping of autonomic/sympathetic candidate genetic loci for hypertension in the human genome: a somatic cell radiation hybrid library approach. Journal of Human Hypertension. 17: 319-24. PMID 12756404 DOI: 10.1038/sj.jhh.1001550  0.48
2003 Wong CM, O'Connor DT, Martinez JA, Kailasam MT, Parmer RJ. Diminished renal kallikrein responses to mineralocorticoid stimulation in African Americans: determinants of an intermediate phenotype for hypertension. American Journal of Hypertension. 16: 281-9. PMID 12670744 DOI: 10.1016/S0895-7061(03)00002-5  0.48
2002 O'Connor DT, Kailasam MT, Kennedy BP, Ziegler MG, Yanaihara N, Parmer RJ. The catecholamine release-inhibitory "catestatin" region of chromogranin a: early decline in humans at genetic risk of hypertension. Annals of the New York Academy of Sciences. 971: 533-5. PMID 12438176  0.48
2002 Parmer RJ, Zinder O. Catecholaminergic pathways, chromaffin cells, and human disease. Annals of the New York Academy of Sciences. 971: 497-505. PMID 12438170  0.48
2002 Miles LA, Hawley SB, Parmer RJ. Chromaffin cell plasminogen receptors. Annals of the New York Academy of Sciences. 971: 454-9. PMID 12438164  0.48
2002 Jiang Q, Yasothornsrikul S, Taupenot L, Miles LA, Parmer RJ. The local chromaffin cell plasminogen/plasmin system and the regulation of catecholamine secretion. Annals of the New York Academy of Sciences. 971: 445-9. PMID 12438162  0.48
2002 Taupenot L, Harper KL, Mahapatra NR, Parmer RJ, O'Connor DT. Intracellular protein trafficking into catecholamine storage vesicles: novel chimeric photoproteins visualized by deconvolution fluorescence microscopy. Annals of the New York Academy of Sciences. 971: 262-5. PMID 12438129  0.48
2002 Taupenot L, Harper KL, Mahapatra NR, Parmer RJ, Mahata SK, O'Connor DT. Identification of a novel sorting determinant for the regulated pathway in the secretory protein chromogranin A. Journal of Cell Science. 115: 4827-41. PMID 12432071 DOI: 10.1242/jcs.00140  0.48
2002 Bannach FG, Gutierrez A, Fowler BJ, Bugge TH, Degen JL, Parmer RJ, Miles LA. Localization of regulatory elements mediating constitutive and cytokine-stimulated plasminogen gene expression. The Journal of Biological Chemistry. 277: 38579-88. PMID 12149246 DOI: 10.1074/jbc.M202509200  0.48
2002 O'Connor DT, Kailasam MT, Kennedy BP, Ziegler MG, Yanaihara N, Parmer RJ. Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension. Journal of Hypertension. 20: 1335-45. PMID 12131530 DOI: 10.1097/00004872-200207000-00020  0.48
2002 Zhang L, Seiffert D, Fowler BJ, Jenkins GR, Thinnes TC, Loskutoff DJ, Parmer RJ, Miles LA. Plasminogen has a broad extrahepatic distribution. Thrombosis and Haemostasis. 87: 493-501. PMID 11916082  0.48
2001 Jiang Q, Taupenot L, Mahata SK, Mahata M, O'Connor DT, Miles LA, Parmer RJ. Proteolytic cleavage of chromogranin A (CgA) by plasmin. Selective liberation of a specific bioactive CgA fragment that regulates catecholamine release. The Journal of Biological Chemistry. 276: 25022-9. PMID 11342539 DOI: 10.1074/jbc.M101545200  0.48
2001 O'Connor DT, Tyrell EA, Kailasam MT, Miller LM, Martinez JA, Henry RR, Parmer RJ, Gabbai FB. Early alteration in glomerular reserve in humans at genetic risk of essential hypertension: mechanisms and consequences. Hypertension. 37: 898-906. PMID 11244015  0.48
2001 Timberlake DS, O'Connor DT, Parmer RJ. Molecular genetics of essential hypertension: recent results and emerging strategies. Current Opinion in Nephrology and Hypertension. 10: 71-9. PMID 11195056 DOI: 10.1097/00041552-200101000-00012  0.48
2000 O'Connor DT, Mahata SK, Taupenot L, Mahata M, Livsey Taylor CV, Kailasam MT, Ziegler MG, Parmer RJ. Chromogranin A in human disease. Advances in Experimental Medicine and Biology. 482: 377-88. PMID 11192598 DOI: 10.1007/0-306-46837-9_31  0.48
2000 Mahata SK, Mahata M, Livsey Taylor CV, Taupenot L, Parmer RJ, O'Connor DT. The novel catecholamine release-inhibitory peptide catestatin (chromogranin A344-364). Properties and function. Advances in Experimental Medicine and Biology. 482: 263-77. PMID 11192587 DOI: 10.1007/0-306-46837-9_21  0.48
2000 Parmer RJ, Mahata SK, Jiang Q, Taupenot L, Gong Y, Mahata M, O'Connor DT, Miles LA. Tissue plasminogen activator and chromaffin cell function. Advances in Experimental Medicine and Biology. 482: 179-92. PMID 11192579 DOI: 10.1007/0-306-46837-9_14  0.48
2000 Lacy F, Kailasam MT, O'Connor DT, Schmid-Schönbein GW, Parmer RJ. Plasma hydrogen peroxide production in human essential hypertension: Role of heredity, gender, and ethnicity Hypertension. 36: 878-884. PMID 11082160  0.48
2000 Kailasam MT, Parmer RJ, Tyrell EA, Henry RR, O'Connor DT. Circulating amylin in human essential hypertension: Heritability and early increase in individuals at genetic risk Journal of Hypertension. 18: 1611-1620. PMID 11081774  0.48
2000 Taupenot L, Mahata SK, Mahata M, Parmer RJ, O'Connor DT. Interaction of the catecholamine release-inhibitory peptide catestatin (human chromogranin A352-372) with the chromaffin cell surface and Torpedo electroplax: Implications for nicotinic cholinergic antagonism Regulatory Peptides. 95: 9-17. PMID 11062327 DOI: 10.1016/S0167-0115(00)00135-X  0.48
2000 Parmer RJ, Mahata M, Gong Y, Mahata SK, Jiang Q, O'Connor DT, Xi XP, Miles LA. Processing of chromogranin A by plasmin provides a novel mechanism for regulating catecholamine secretion. The Journal of Clinical Investigation. 106: 907-15. PMID 11018079 DOI: 10.1172/JCI7394  0.48
2000 O'Connor DT, Insel PA, Ziegler MG, Hook VY, Smith DW, Hamilton BA, Taylor PW, Parmer RJ. Heredity and the autonomic nervous system in human hypertension. Current Hypertension Reports. 2: 16-22. PMID 10982526 DOI: 10.1007/s11906-000-0053-8  0.48
2000 Herrmann V, Büscher R, Go MM, Ring KM, Hofer JK, Kailasam MT, O'Connor DT, Parmer RJ, Insel PA. Beta2-adrenergic receptor polymorphisms at codon 16, cardiovascular phenotypes and essential hypertension in whites and African Americans. American Journal of Hypertension. 13: 1021-6. PMID 10981553 DOI: 10.1016/S0895-7061(00)01188-2  0.48
2000 Song CK, Martinez JA, Kailasam MT, Dao TT, Wong CM, Parmer RJ, O'Connor DT. Renal kallikrein excretion: role of ethnicity, gender, environment, and genetic risk of hypertension. Journal of Human Hypertension. 14: 461-8. PMID 10918552  0.48
2000 González-Trápaga JL, Nelesen RA, Dimsdale JE, Mills PJ, Kennedy B, Parmer RJ, Ziegler MG. Plasma epinephrine levels in hypertension and across gender and ethnicity. Life Sciences. 66: 2383-92. PMID 10864100  0.48
2000 Taylor CV, Taupenot L, Mahata SK, Mahata M, Wu H, Yasothornsrikul S, Toneff T, Caporale C, Jiang Q, Parmer RJ, Hook VY, O'Connor DT. Formation of the catecholamine release-inhibitory peptide catestatin from chromogranin A. Determination of proteolytic cleavage sites in hormone storage granules. The Journal of Biological Chemistry. 275: 22905-15. PMID 10781584 DOI: 10.1074/jbc.M001232200  0.48
1999 O'Connor DT, Takiyyuddin MA, Printz MP, Dinh TQ, Barbosa JA, Rozansky DJ, Mahata SK, Wu H, Kennedy BP, Ziegler MG, Wright FA, Schlager G, Parmer RJ. Catecholamine storage vesicle protein expression in genetic hypertension. Blood Pressure. 8: 285-95. PMID 10803489  0.48
1999 Büscher R, Herrmann V, Ring KM, Kailasam MT, O'Connor DT, Parmer RJ, Insel PA. Variability in phenylephrine response and essential hypertension: a search for human alpha(1B)-adrenergic receptor polymorphisms. The Journal of Pharmacology and Experimental Therapeutics. 291: 793-8. PMID 10525102  0.48
1999 Mahata SK, Mahata M, Wu H, Parmer RJ, O'Connor DT. Neurotrophin activation of catecholamine storage vesicle protein gene expression: Signaling to chromogranin a biosynthesis Neuroscience. 88: 405-424. PMID 10197763 DOI: 10.1016/S0306-4522(98)00225-5  0.48
1999 Mahata SK, Mahata M, Parmer RJ, O'Connor DT. Desensitization of catecholamine release: The novel catecholamine release-inhibitory peptide catestatin (chromogranin A344-364) acts at the receptor to prevent nicotinic cholinergic tolerance Journal of Biological Chemistry. 274: 2920-2928. PMID 9915830 DOI: 10.1074/jbc.274.5.2920  0.48
1998 Kailasam MT, Martinez JA, Cervenka JH, Yen SS, O'connor DT, Parmer RJ. Racial differences in renal kallikrein excretion: effect of the ovulatory cycle. Kidney International. 54: 1652-8. PMID 9844141 DOI: 10.1046/j.1523-1755.1998.00147.x  0.48
1998 Mahata M, Mahata SK, Parmer RJ, O'Connor DT. Proadrenomedullin N-terminal 20 peptide: Minimal active region to regulate nicotinic receptors Hypertension. 32: 907-916. PMID 9822452  0.48
1998 Tsigelny I, Mahata SK, Taupenot L, Preece NE, Mahata M, Khan I, Parmer RJ, O'Connor DT. Mechanism of action of chromogranin A on catecholamine release: Molecular modeling of the catestatin region reveals a β-strand/loop/β-strand structure secured by hydrophobic interactions and predictive of activity Regulatory Peptides. 77: 43-53. PMID 9809795 DOI: 10.1016/S0167-0115(98)00040-8  0.48
1998 Fowler B, Mackman N, Parmer RJ, Miles LA. Binding of human single chain urokinase to Chinese Hamster Ovary cells and cloning of hamster u-PAR. Thrombosis and Haemostasis. 80: 148-54. PMID 9684801  0.48
1998 Dao TT, Kailasam MT, Parmer RJ, Le HV, Le Verge R, Kennedy BP, Ziegler G, Insel PA, Wright FA, O'Connor DT. Expression of altered alpha2-adrenergic phenotypic traits in normotensive humans at genetic risk of hereditary (essential) hypertension. Journal of Hypertension. 16: 779-92. PMID 9663918 DOI: 10.1097/00004872-199816060-00009  0.48
1998 Mahata SK, Mahata M, Yoo SH, Taupenot L, Wu H, Aroda VR, Livsey CV, Taulane JP, Goodman M, Parmer RJ, O'Connor DT. A novel, catecholamine release-inhibitory peptide from chromogranin A: autocrine control of nicotinic cholinergic-stimulated exocytosis Advances in Pharmacology (San Diego, Calif.). 42: 260-264. PMID 9327894 DOI: 10.1016/S1054-3589(08)60743-7  0.48
1998 Parmer RJ, Miles LA. Targeting of tissue plasminogen activator to the regulated pathway of secretion Trends in Cardiovascular Medicine. 8: 306-312. DOI: 10.1016/S1050-1738(98)00025-5  0.48
1997 Mahata SK, O'Connor DT, Mahata M, Yoo SH, Taupenot L, Wu H, Gill BM, Parmer RJ. Novel autocrine feedback control of catecholamine release: A discrete chromogranin A fragment is a noncompetitive nicotinic cholinergic antagonist Journal of Clinical Investigation. 100: 1623-1633. PMID 9294131  0.48
1997 Tang K, Wu H, Mahata SK, Mahata M, Gill BM, Parmer RJ, O'Connor DT. Stimulus coupling to transcription versus secretion in pheochromocytoma cells. Convergent and divergent signal transduction pathways and the crucial roles for route of cytosolic calcium entry and protein kinase C Journal of Clinical Investigation. 100: 1180-1192. PMID 9276735  0.48
1997 Jenkins GR, Seiffert D, Parmer RJ, Miles LA. Regulation of plasminogen gene expression by interleukin-6. Blood. 89: 2394-403. PMID 9116283  0.48
1997 Parmer RJ, Mahata M, Mahata S, Sebald MT, O'Connor DT, Miles LA. Tissue plasminogen activator (t-PA) is targeted to the regulated secretory pathway. Catecholamine storage vesicles as a reservoir for the rapid release of t-PA. The Journal of Biological Chemistry. 272: 1976-82. PMID 8999889 DOI: 10.1074/jbc.272.3.1976  0.48
1996 Kailasam MT, O'Connor DT, Parmer RJ. Hereditary intermediate phenotypes in African American hypertension Ethnicity and Health. 1: 117-128. PMID 9395555  0.48
1996 Tang K, Wu H, Mahata SK, Taupenot L, Rozansky DJ, Parmer RJ, O'Connor DT. Stimulus-transcription coupling in pheochromocytoma cells: Promoter region-specific activation of chromogranin A biosynthesis Journal of Biological Chemistry. 271: 28382-28390. PMID 8910462 DOI: 10.1074/jbc.271.45.28382  0.48
1996 Brinton TJ, Kailasam MT, Wu RA, Cervenka JH, Chio SS, Parmer RJ, DeMaria AN, O'Connor DT. Arterial compliance by cuff sphygmomanometer. Application to hypertension and early changes in subjects at genetic risk. Hypertension. 28: 599-603. PMID 8843884  0.48
1996 Mahata M, Mahata SK, Parmer RJ, O'Connor DT. Vesicular monoamine transport inhibitors: Novel action at calcium channels to prevent catecholamine secretion Hypertension. 28: 414-420. PMID 8794826  0.48
1996 Eskeland NL, Zhou A, Dinh TQ, Wu H, Parmer RJ, Mains RE, O'Connor DT. Chromogranin A processing and secretion: specific role of endogenous and exogenous prohormone convertases in the regulated secretory pathway. The Journal of Clinical Investigation. 98: 148-56. PMID 8690787 DOI: 10.1172/JCI118760  0.48
1996 O'Connor DT, Kailasam MT, Parmer RJ. Complex trait genetics: new methods yield a result for essential hypertension The Journal of Clinical Investigation. 97: 1997-1998. PMID 8621786  0.48
1996 Jenkins GR, Seiffert D, Parmer RJ, Miles LA. Interleukin-6 regulates plasminogen gene expression Fibrinolysis. 10: 94.  0.48
1996 Parmer RJ, Mahala M, Mahata S, Sebald MT, O'Connor DT, Miles LA. Tissue plasminogen activator (t-pa) is targeted to the regulated secretory pathway: catecholamine storage vesicles as a reservoir for the rapid release of t-Pa Fibrinolysis. 10: 86.  0.48
1995 Kailasam MT, Parmer RJ, Stone RA, Shankel S, Kennedy BP, Ziegler MG, O'Connor DT. Factitious pheochromocytoma: novel mimickry by Valsalva maneuver and clues to diagnosis. American Journal of Hypertension. 8: 651-5. PMID 7662252 DOI: 10.1016/0895-7061(95)00076-2  0.48
1995 Wu H, Mahata SK, Mahata M, Webster NJG, Parmer RJ, O'Connor DT. A functional cyclic AMP response element plays a crucial role in neuroendocrine cell type-specific expression of the secretory granule protein chromogranin A Journal of Clinical Investigation. 96: 568-578. PMID 7615829  0.48
1995 Takiyyuddin MA, Parmer RJ, Kailasam MT, Cervenka JH, Kennedy B, Ziegler MG, Lin MC, Li J, Grim CE, Wright FA. Chromogranin A in human hypertension. Influence of heredity. Hypertension. 26: 213-20. PMID 7607727  0.48
1995 Kailasam MT, Parmer RJ, Cervenka JH, Wu RA, Ziegler MG, Kennedy BP, Adegbile IA, O'Connor DT. Divergent effects of dihydropyridine and phenylalkylamine calcium channel antagonist classes on autonomic function in human hypertension. Hypertension. 26: 143-9. PMID 7607717  0.48
1995 Cubeddu LX, O’Connor DT, Hoffmann I, Parmer RJ. Plasma chromogranin a marks emesis and serotonin release associated with dacarbazine and nitrogen mustard but not with cyclophosphamide-based chemotherapies British Journal of Cancer. 72: 1033-1038. PMID 7547218 DOI: 10.1038/bjc.1995.457  0.48
1995 Cubeddu LX, O'Connor DT, Parmer RJ. Plasma chromogranin A: A marker of serotonin release and of emesis associated with cisplatin chemotherapy Journal of Clinical Oncology. 13: 681-687. PMID 7533826  0.48
1994 O'Connor DT, Cervenka JH, Stone RA, Levine GL, Parmer RJ, Franco-Bourland RE, Madrazo I, Langlais PJ, Robertson D, Biaggioni I. Dopamine beta-hydroxylase immunoreactivity in human cerebrospinal fluid: properties, relationship to central noradrenergic neuronal activity and variation in Parkinson's disease and congenital dopamine beta-hydroxylase deficiency. Clinical Science (London, England : 1979). 86: 149-58. PMID 8143425  0.48
1994 Parmer RJ, Stone RA, Cervenka JH. Renal hemodynamics in essential hypertension. Racial differences in response to changes in dietary sodium. Hypertension. 24: 752-7. PMID 7995633  0.48
1994 Rozansky DJ, Wu H, Tang K, Parmer RJ, O'Connor DT. Glucocorticoid activation of chromogranin A gene expression: Identification and characterization of a novel glucocorticoid response element Journal of Clinical Investigation. 94: 2357-2368. PMID 7989592  0.48
1994 O'Connor DT, Wu H, Gill BM, Rozansky DJ, Tang K, Mahata SK, Mahata M, Eskeland NL, Videen JS, Zhang X, Takiyyuddin MA, Parmer RJ. Hormone storage vesicle proteins. Transcriptional basis of the widespread neuroendocrine expression of chromogranin A, and evidence of its diverse biological actions, intracellular and extracellular Annals of the New York Academy of Sciences. 733: 36-45. PMID 7978886 DOI: 10.1111/j.1749-6632.1994.tb17254.x  0.48
1994 Kailasam MT, Lin MC, Cervenka JH, Parmer RJ, Kennedy BP, Ziegler MG, O'Connor DT. Effects of an oral prostaglandin E1 agonist on blood pressure and its determinants in essential hypertension. Journal of Human Hypertension. 8: 515-20. PMID 7932515  0.48
1994 Takiyyuddin MA, Brown MR, Dinh TQ, Cervenka JH, Braun SD, Parmer RJ, Kennedy B, O'Connor DT. Sympatho-adrenal secretion in humans: factors governing catecholamine and storage vesicle peptide co-release. Journal of Autonomic Pharmacology. 14: 187-200. PMID 7929473  0.48
1994 Wu RA, Kailasam MT, Cervenka JH, Parmer RJ, Kennedy BP, Ziegler MG, O'Connor DT. Does lipophilicity of angiotensin converting enzyme inhibitors selectively influence autonomic neural function in human hypertension? Journal of Hypertension. 12: 1243-7. PMID 7868871  0.48
1993 Takiyyuddin MA, De Nicola L, Gabbai FB, Dinh TQ, Kennedy B, Ziegler MG, Sabban EL, Parmer RJ, O'Connor DT. Catecholamine secretory vesicles. Augmented chromogranins and amines in secondary hypertension. Hypertension. 21: 674-9. PMID 8491501  0.48
1993 Parmer RJ, Miles LA, Xi XP, Gill BM, Wu HJ, O'Connor DT. Processing of chromaffin granule proteins: a profusion of proteases? Neurochemistry International. 22: 361-7. PMID 8457772 DOI: 10.1016/0197-0186(93)90018-Z  0.48
1993 Simon-Chazottes D, Wu H, Parmer RJ, Rozansky DJ, Szpirer J, Levan G, Kurtz TW, Szpirer C, Guenet JL, O'Connor DT. Assignment of the Chromogranin A (Chga) Locus to Homologous Regions on Mouse Chromosome 12 and Rat Chromosome 6 Genomics. 17: 252-255. PMID 8406464 DOI: 10.1006/geno.1993.1316  0.48
1993 Parmer RJ, Xi XP, Wu HJ, Helmen LJ, Petz LN. Secretory protein traffic: Chromogranin a contains a dominant targeting signal for the regulated pathway Journal of Clinical Investigation. 92: 1042-1054. PMID 8394383  0.48
1993 O'Connor DT, Cervenka JH, Stone RA, Parmer RJ, Franco-Bourland RE, Madrazo I, Langlais PJ. Chromogranin A immunoreactivity in human cerebrospinal fluid: properties, relationship to noradrenergic neuronal activity, and variation in neurologic disease. Neuroscience. 56: 999-1007. PMID 7904334 DOI: 10.1016/0306-4522(93)90146-7  0.48
1992 Parmer RJ, Cervenka JH, Stone RA. Baroreflex sensitivity and heredity in essential hypertension. Circulation. 85: 497-503. PMID 1735146  0.48
1991 Hsiao RJ, Parmer RJ, Takiyyuddin MA, O'connor DT. Chromogranin a storage and secretion: Sensitivity and specificity for the diagnosis of pheochromocytoma Medicine (United States). 70: 33-45. PMID 1988765  0.48
1991 Takiyyuddin MA, Baron AD, Cervenka JH, Barbosa JA, Neumann HP, Parmer RJ, Sullivan PA, O'Connor DT. Suppression of chromogranin-A release from neuroendocrine sources in man: pharmacological studies. The Journal of Clinical Endocrinology and Metabolism. 72: 616-22. PMID 1671783 DOI: 10.1210/jcem-72-3-616  0.48
1991 Sica DA, Cutler RE, Parmer RJ, Ford NF. Comparison of the Steady-State Pharmacokinetics of Fosinopril, Lisinopril and Enalapril in Patients with Chronic Renal Insufficiency Clinical Pharmacokinetics. 20: 420-427. PMID 1652404 DOI: 10.2165/00003088-199120050-00006  0.48
1990 Takiyyuddin MA, Cervenka JH, Hsiao RJ, Barbosa JA, Parmer RJ, O'Connor DT. Chromogranin A. Storage and release in hypertension. Hypertension. 15: 237-46. PMID 2406199  0.48
1990 Takiyyuddin MA, Cervenka JH, Sullivan PA, Pandian MR, Parmer RJ, Barbosa JA, O'Connor DT. Is physiologic sympathoadrenal catecholamine release exocytotic in humans? Circulation. 81: 185-95. PMID 2404624  0.48
1990 Hsiao RJ, Parmer RJ, Barbosa JA, O'Connor DT, Neumann HPH. Chromogranin A in familial pheochromocytoma: Diagnostic screening value, prediction of tumor mass, and post-resection kinetics indicating two-compartment distribution The American Journal of Medicine. 88: 607-613. PMID 2189303 DOI: 10.1016/0002-9343(90)90526-J  0.48
1990 Lahr G, Heiss C, Mayerhofer A, Schilling K, Parmer RJ, O'Connor DT, Gratzl M. Chromogranin A in the olfactory system of the rat. Neuroscience. 39: 605-11. PMID 2097516 DOI: 10.1016/0306-4522(90)90245-Y  0.48
1990 O'Connor DT, Takiyyuddin MA, Cervenka JH, Parmer RJ, Barbosa JA, Chang YM, Hsiao RJ. Circulating chromogranin A as a diagnostic tool in clinical chemistry. Acta Histochemica. Supplementband. 38: 27-33. PMID 2080246  0.48
1990 Parmer RJ, Cervenka JH, Stone RA, O'Connor DT. Autonomic function in hypertension. Are there racial differences? Circulation. 81: 1305-11. PMID 1969334  0.48
1989 Parmer RJ, Koop AH, Handa MT, O'Connor DT. Molecular cloning of chromogranin A from rat pheochromocytoma cells Hypertension. 14: 435-444. PMID 2793216  0.48
1988 Parmer RJ, O’Connor DT. Enkephalins in human phaeochromocytomas: Localization in immunoreactive, high molecular weight form to the soluble core of chromaffin granules Journal of Hypertension. 6: 187-198. PMID 3361117  0.48
1987 O'Connor DT, Strause L, Saltman P, Parmer RJ, Cervenka J. Serum zinc is unaffected by effective captopril treatment of hypertension. Journal of Clinical Hypertension. 3: 405-8. PMID 3330985  0.48
1986 Deftos LJ, Murray SS, Burton DW, Parmer RJ, O'Connor DT, Delegeane AM, Mellon PL. A cloned chromogranin a (CgA) cDNA detects a 2.3Kb mRNA in diverse neuroendocrine tissues Biochemical and Biophysical Research Communications. 137: 418-423. PMID 3718511 DOI: 10.1016/0006-291X(86)91226-X  0.48
1985 Parmer RJ, Mosley C, O'Connor DT. Enkephalins in pheochromocytoma: studies in a rat model. Clinical and Experimental Hypertension. Part a, Theory and Practice. 7: 483-512. PMID 2408793 DOI: 10.3109/10641968509077208  0.48
1984 O'Connor DT, Parmer RJ, Deftos LJ. Chromogranin A: studies in the endocrine system Transactions of the Association of American Physicians. 97: 242-250. PMID 6535341  0.48
Show low-probability matches.